AGENTIC AI: ACCELERATING PHARMA LAUNCHES WITH AUTONOMOUS EXECUTION
Pharmaceutical launches have never been more complex - or more consequential. Agentic AI, autonomous digital agents that plan, execute, and iterate workflows enabled by human experience, is emerging as a transformative force in how drugmakers bring products to market. By acting as digital teammates, these agents free human talent for strategic decision-making while accelerating execution across three critical areas: compressing information lag from weeks to a day, driving efficiency gains in functions like compliance, and empowering sales reps to become 3-4x more effective - enabling even lean teams to compete with larger salesforces.
Find out how leaders are harnessing agentic AI across workflows – download our new whitepaper today  >>>
Harnessing agentic AI isn’t a nice to have - it’s a strategic imperative that will set you apart from competitors and build long term trust with customers and other external stakeholders. 
Download our brand-new whitepaper today to see real-life use cases of how agentic AI has been used to:
  • Compress timelines: Enable real-time decision making and faster course corrections
  • Maximise efficiency: Harness agentic AI to free up human talent to allow for more focus on high-level, strategic impact
  • Empower sales: Increase salesforce effectiveness with decisions backed with real-time customer insights 
Don’t miss out, download our exclusive whitepaper today to find out where agentic AI could improve your workstream >>>
Please let me know if you have any feedback, or if you want to get involved with the event.

Kind regards,
Daisy Beale
Senior Conference Producer
Pharma
Reuters Events
Phone: +44 20 3197 3016
Download our brand-new whitepaper today

Fill in the form below to have your whitepaper sent directly to your inbox:
Please tick this box to give Reuters Events permission to provide my contact information to Cogizant - https://www.cognizant.com/us/en- so Cognizant can share the latest Cognizant news and offers with me by email or telephone.
You may unsubscribe from receiving news and offers from the sender at any time by following the instructions in the communications received. Cognizant handles your information as described in the Cognizant Privacy Notice - https://www.cognizant.com/us/en/privacy-notice
I consent to Thomson Reuters using the personal information provided above to send me marketing communications about its products and services. I understand I can opt-out at any time.
By submitting this form, you acknowledge the Thomson Reuters group of companies will process your personal information as described in our Privacy Statement
which explains how we collect, use, store, and disclose your personal information, the consequences if you do
not provide this information, and the way in which you
can access and correct your personal information or submit a complaint.
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.